(Q73599620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9262548%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

1 reference

title

AIDS and ophthalmology: a period of transition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9262548%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

D A Jabs

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9262548%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J G Bartlett

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9262548%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9262548%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Ophthalmology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9262548%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9262548%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

227-233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9262548%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9262548%20AND%20SRC:MED&resulttype=core&format=json

Natural history of opportunistic disease in an HIV-infected urban clinical cohort

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

The immunopathogenesis of human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Workin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Preliminary analysis of the Concorde trial. Concorde Coordinating Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Antiviral chemoprophylaxis after occupational exposure to human immunodeficiency virus: why, when, where, and what

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Resolution of cytomegalovirus retinitis with zidovudine therapy. Case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Regression of cytomegalovirus retinitis with zidovudine. A clinicopathologic correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Analysis of visual dysfunctions in HIV-positive patients without retinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Cli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Elevation of laser flare photometry in patients with cytomegalovirus retinitis and AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

BW B759U for cytomegalovirus retinitis: intraocular drug penetration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

Atypical retinitis in patients with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970789-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9394(14)70789-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9262548%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference